David A. Greenblatt

Board Director

Director

Cavco Industries Inc.Cavco Industries, Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 1 buy · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€157k

▼ Sales (0 ops.)

—

Latest filing published 29 Jul 2026 for Cavco Industries, INC.. Read the official filing

Filing timeline

BuySale

David A. Greenblatt

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

David A. Greenblatt: trading record in brief

David A. Greenblatt is a declared insider of Cavco Industries Inc. (board member), with filings sourced from SEC (Form 4). Between 5 August 2021 and 27 July 2026, the trades on record add up to 10 filings.

No open-market sale appears; the market trades are 1 purchase worth €157k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants and 3 option exercises. So far in 2026, the count stands at 1 purchase and no sales.

The newest entry dates from 29 July 2026: a share grant, in Cavco Industries Inc. The last insider purchase was made public on 5 February 2026, 255 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.